Allscripts (MDRX) Tops Q2 EPS by 2c
More News related to MDRX
- Kindred Healthcare, Nation's Largest Post-Acute Healthcare Provider, Selects Allscripts Referral Management
- Edward Health Service Corporation Selects Allscripts Electronic Health Record and Practice Management
- Red Hat, Inc.'s Matthew Szulik Named Ernst & Young Entrepreneur Of The Year(R) 2008 Overall National Winner
- Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024
- Allscripts (MDRX) Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell
More News related to Earnings
- The Hartford (HIG) Talks About Its Highly Rated CMBS Portfolio
- PepsiCo (PEP) to Invest $3 Billion in Mexico Operations
- Quicksilver Resources (KWK) Announces '09 Capital Budget
- Cosi, Inc. (COSI) Forms Special Committee to Review Strategic Alternatives
- Par Pharmaceutical (PRX) Halts Shipments of of Budesonide Inhalation Suspension
Allscripts (Nasdaq: MDRX) reports Q2 EPS of $0.13, 2 cents better than the analyst estimate of $0.11. Revenues for the quarter were $81.5 million, versus the consensus of $76.94 million.
Related Categories
EarningsStocks Mentioned
-0.21Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
